Background and Aims Chronic kidney disease (CKD) is a major health problem worldwide. The last stage of CKD is end-stage renal disease (ESRD), which is characterized by a progressive decrease in glomerular filtration rate (GFR). End-stage renal failure is often complicated by anemia, uremic cardiomyopathy, and renal osteodystrophy, which can be fatal. Therefore, it is necessary to identify the risk factors that can lead to ESRD or death. In addition to well-defined early markers such as diabetes, hypertension, and obesity, it is necessary to identify other markers that would help in the prediction of the disease. It has been shown that genetic factors also have an influence on renal function, pathogenesis, and disease progression, which is confirmed by the results of genome-wide association studies (GWASs). The results of GWASs show that glomerular filtration rate and renal function are affected by several gene loci. Galectin 3 (Gal-3) is the only representative chimera type of the galectin family, which forms a pentameric structure on the cell surface after binding to glycoproteins or glycolipids. The results of numerous studies have shown that Gal-3 plays a significant role in fibrosis, inflammation, and proliferation. Increased circulating levels of Gal-3 have been associated with various diseases, including cancer, immunological disorders, and cardiovascular disease. Method A total of 108 ESRD patients and 38 healthy controls were enrolled in the study. Genotyping of LGALS3 geners 4644, rs4652, and rs11125 polymorphisms was performed by polymerase chain reaction–restriction fragment length polymorphism (PCR-RFLP). Results By multivariate logistic regression analysis, we found that LGALS3 rs4644 CC and rs4652 AA genotypes were significantly associated with a higher risk for lower hemoglobin, higher level of parathyroid hormone, and also occurrence of diabetes mellitus and arterial hypertension. The CAA haplotype was significantly more common in patients with diabetes, low hemoglobin level, and normal PTH level. It has been observed as well that the ACT haplotype was more common in patients with low glomerular filtration, lowPTH, and normal hemoglobin level. Conclusion We found that the LGALS3 rs4644 and rs4652 gene polymorphism may be involved in the pathogenesis and appearance of complications in ESRD patients and thus could be considered a new genetic risk factor in this population.
This review aimed to revisit the old and introduce some of the new various cardioprotective effects of physical exercise, focusing on ischemia-reperfusion injury. A wealth of data shows that regular physical exercise is necessary to prevent cardiovascular diseases. In the last few years, a number of new training regimes, usually modified variations of high-intensity interval training (HIIT) and moderate-intensity continuous training (MICT) protocols, have been rising in popularity among people of all ages. Since exercising is not limited to only healthy people, our study emphasized the benefits of HIIT and MICT in preventing or mitigating cardiac ischemia-reperfusion injury. Different kinds of research are being performed, studying the various positive and side effects of these training regimes, all in hopes of finding the most optimal ones. So far, all of them have shown that exercising to any extent, even for a short period of time, is beneficial in one way or another, and outweighs the possible risks it might have. We also revisited some of the known molecular mechanisms responsible for many of the effects of physical exercise and introduced some new findings related to them. Lastly, we summarized and compared the benefits of different HIIT and MICT protocols to narrow down the search for the most efficient training method.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.